- conservative treatment,
- veins of dural sinus
How to Cite
Copyright (c) 2021 Aleksandra Gavrilovska-Dimovska, Andreja Gavrilovski, Venko Filipce
This work is licensed under a Creative Commons Attribution 4.0 International License.
Cerebral venous sinus thrombosis (CVST) is presence of a blood clot in the dural venous sinuses. This is a rare, but dangerous condition. CSVT is characterized by a highly variable clinical spectrum, difficult diagnosis, variable etiologies and prognosis. The International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT) determined the frequency of the sites of SCVT. The aim of this case study was to show the clinical presentation, the examination we made, the therapy that was ordinated and the outcome of the treatment. Case study: A 14-year-old male teenager was admitted to the University Clinic for Neurosurgery in Skopje with GCS 10, accompanied with tonic-clonic epileptic seizures. CT examinations by systems were made, and during the time of recording the patient was given Dormicum 2mg overall dose. CT scan of the brain showed hyperdense zones formation around superior sagittal sinus (SSS), the rest of the medical finding was normal. We ran laboratorytests and the test for hemostasisshowed deviation from the normal range. With the ordinated therapy the clinical condition of the patient drastically improved. He was discharged home 12 days after the admission. He was given a recommendation for further check-ups by a transfusiologist and regular visits to our clinic. Occlusion of the cerebral veins and dural venous sinuses may occur on the basis of local trauma, neoplasm or infection. Primary aseptic thrombosis may involve either cerebral veins or dural venous sinuses, or both in combination. The clinical picture and the prognosis of intracranial venous thrombosis probably depend largely on the location, extent, and rapidity of development of the venous occlusion. Conclusion: Superior sagittal sinus thrombosis is a condition that can be manifested with diverse and many symptoms and signs, which often can start unexpectedly and can be life-threatening.
- Wang JW, Li JP, Song YL, Tan K, Wang Y, Li T, et al. Clinical characteristics of cerebral venous sinus thrombosis. Neurosciences 2015; 20:292–5. doi: 10.17712/nsj.2015.3.20140625
- Kashyap AS, Anand KP, Kashyap S. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005; 353:314–5. doi: 10.1056/NEJM200507213530319
- Wang Xin-Hua, Zhang Lin-Mei, Chai Yi-Ming, Wang Ji, Yu Li-Fei, Zhou Shui-Zhen. Clinical characteristics and outcomes of pediatric cerebral venous sinus thrombosis: An analysis of 30 cases in China. Front Pediatr 2019; 7:364 doi: 10.3389/fped.2019.00364.
- Lebas A, Chabrier S, Fluss J, Gordon K, Kossorotoff M, Nowak-Gottl U, et al. EPNS/SFNP guideline on the anticoagulant treatment of cerebral sinovenous thrombosis in children and neonates. Eur J Paediatr Neurol 2012; 16:219–28. doi: 10.1016/j.ejpn.2012.02.005
- Roach ES, Golomb MR, Adams R, Biller J, Daniels S, Deveber G, et al. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 2008; 39:2644–91. doi: 10.1161/STROKEAHA.108.189696
- Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol 2007; 6:162–70. doi: 10.1016/S1474-4422(07)70029-7
- Qu H, Yang M. Early imaging characteristics of 62 cases of cerebral venous sinus thrombosis. Exp Ther Med. 2013; 5:233–6. doi: 10.3892/etm.2012.796
- Coutinho JM, Ferro JM, Canhao P, Barinagarrementeria F, Bousser MG, Stam J, et al. Unfractionated or low-molecular weight heparin for the treatment of cerebral venous thrombosis. Stroke 2010; 41:2575–80. doi: 10.1161/STROKEAHA.110.588822